OVARIAN NEOPLASMS
Clinical trials for OVARIAN NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new OVARIAN NEOPLASMS trials appear
Sign up with your email to follow new studies for OVARIAN NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major trial aims to extend life for women with advanced ovarian cancer
Disease control OngoingThis large, late-stage study is testing whether adding two newer drugs (dostarlimab and niraparib) to standard chemotherapy works better than standard care alone for women newly diagnosed with advanced ovarian cancer. The main goal is to see if the new combination can keep the ca…
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE3 • Sponsor: Tesaro, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New pill targets Cancer's genetic weakness in first human trial
Disease control OngoingThis is a first-in-human study to find a safe dose and see how the body processes a new oral drug called ATV-1601. It is being tested in adults with advanced solid tumors, including certain breast cancers, that have a specific genetic change called an AKT1 E17K mutation. The main…
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE1 • Sponsor: Atavistik Bio, Inc • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New drug shows promise in keeping advanced ovarian cancer at bay
Disease control OngoingThis study tested whether taking the drug niraparib as ongoing 'maintenance' therapy could help keep advanced ovarian cancer from returning after successful initial chemotherapy. It involved 733 women with Stage III or IV ovarian cancer who had responded well to their first round…
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE3 • Sponsor: Tesaro, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New 'Smart Bomb' drug enters human testing for Tough-to-Treat cancers
Disease control OngoingThis is an early-stage study testing a new experimental drug called SGN-MesoC2 in people with advanced solid tumors that have come back or stopped responding to standard treatments. The main goal is to find a safe dose and see how the body handles the drug. The drug is designed t…
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Personalized cancer vaccine aims to keep ovarian cancer at bay
Disease control OngoingThis study is testing whether a personalized vaccine called Vigil can help women with advanced ovarian cancer stay cancer-free longer after their initial surgery and chemotherapy. The vaccine is made from each patient's own tumor cells and is given as a series of injections. Rese…
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE2 • Sponsor: Gradalis, Inc. • Aim: Disease control
Last updated Mar 18, 2026 14:42 UTC
-
Targeted cancer therapy shows promise for multiple tumor types
Disease control OngoingThis study is testing an experimental drug called disitamab vedotin for adults with advanced or metastatic solid tumors that have a specific marker called HER2. The trial includes people with head and neck, lung, ovarian, or endometrial cancers who have already tried other treatm…
Matched conditions: OVARIAN NEOPLASMS
Phase: PHASE2 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
Scientists seek family DNA to unlock Cancer's genetic secrets
Knowledge-focused OngoingThis study aims to understand the genetic causes of cancer that run in families. Researchers are collecting blood or saliva samples from patients with certain cancers and their relatives to build a DNA bank. The goal is to identify genetic patterns that increase cancer risk, whic…
Matched conditions: OVARIAN NEOPLASMS
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC